These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 19208887
1. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. Bobić B, Klun I, Vujanić M, Nikolić A, Ivović V, Živković T, Djurković-Djaković O. J Med Microbiol; 2009 Mar; 58(Pt 3):358-364. PubMed ID: 19208887 [Abstract] [Full Text] [Related]
2. Comparison of two commercially available avidity tests for toxoplasma-specific IgG antibodies. Alvarado-Esquivel C, Sethi S, Janitschke K, Hahn H, Liesenfeld O. Arch Med Res; 2002 Mar; 33(6):520-3. PubMed ID: 12505095 [Abstract] [Full Text] [Related]
4. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. J Clin Microbiol; 2002 Jul; 40(7):2504-8. PubMed ID: 12089270 [Abstract] [Full Text] [Related]
5. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. Iqbal J, Khalid N. J Med Microbiol; 2007 Nov; 56(Pt 11):1495-1499. PubMed ID: 17965351 [Abstract] [Full Text] [Related]
6. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Cozon GJ, Ferrandiz J, Nebhi H, Wallon M, Peyron F. Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):32-6. PubMed ID: 9512179 [Abstract] [Full Text] [Related]
7. Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women. Smets A, Fauchier T, Michel G, Marty P, Pomares C. Parasite; 2016 Jan; 23():45. PubMed ID: 27762213 [Abstract] [Full Text] [Related]
8. Clinical and diagnostic relevance of the Toxoplasma IgG avidity test in the serological surveillance of pregnant women in Austria. Auer H, Vander-Möse A, Picher O, Walochnik J, Aspöck H. Parasitol Res; 2000 Dec; 86(12):965-70. PubMed ID: 11133111 [Abstract] [Full Text] [Related]
9. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm]. Mumcuoglu I, Toyran A, Cetin F, Coskun FA, Baran I, Aksu N, Aksoy A. Mikrobiyol Bul; 2014 Apr; 48(2):283-91. PubMed ID: 24819265 [Abstract] [Full Text] [Related]
10. Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Paul M. Clin Diagn Lab Immunol; 1999 Jul; 6(4):514-8. PubMed ID: 10391853 [Abstract] [Full Text] [Related]
11. Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria. Berredjem H, Aouras H, Benlaifa M, Becheker I, Djebar MR. Afr Health Sci; 2017 Sep; 17(3):647-656. PubMed ID: 29085392 [Abstract] [Full Text] [Related]
12. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis. Tanyuksel M, Guney C, Araz E, Saracli MA, Doganci L. J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650 [Abstract] [Full Text] [Related]
13. [Dating anti-Toxoplasma IgM in pregnancy using VIDAS-ELFA methods]. Pujol-Riqué M, Quintó L, Danés C, Valls ME, Coll O, Moreno A, Jiménez de Anta MT. Enferm Infecc Microbiol Clin; 2000 Sep; 18(6):274-8. PubMed ID: 11075484 [Abstract] [Full Text] [Related]
14. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. Petersen E, Borobio MV, Guy E, Liesenfeld O, Meroni V, Naessens A, Spranzi E, Thulliez P. J Clin Microbiol; 2005 Apr; 43(4):1570-4. PubMed ID: 15814967 [Abstract] [Full Text] [Related]
15. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux). Pelloux H, Brun E, Vernet G, Marcillat S, Jolivet M, Guergour D, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P. Diagn Microbiol Infect Dis; 1998 Oct; 32(2):69-73. PubMed ID: 9823527 [Abstract] [Full Text] [Related]
16. [Evaluation of the usefulness examination of IgG avidity for serodiagnosis of toxoplasmosis]. Sobieszczańska BM. Pol Merkur Lekarski; 2002 Aug; 13(74):111-5. PubMed ID: 12420339 [Abstract] [Full Text] [Related]
17. Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission. Reis MM, Tessaro MM, D'Azevedo PA. Rev Inst Med Trop Sao Paulo; 2006 Aug; 48(2):93-8. PubMed ID: 16699631 [Abstract] [Full Text] [Related]
18. Comparison of the efficiency of two commercial kits - ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women. Sroka J, Wójcik-Fatla A, Zając V, Sawczyn A, Cisak E, Karamon J, Dutkiewicz J, Bojar I. Ann Agric Environ Med; 2016 Dec 23; 23(4):570-575. PubMed ID: 28030925 [Abstract] [Full Text] [Related]
19. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E, French National Reference Center for Toxoplasmosis Network. Clin Vaccine Immunol; 2013 Feb 23; 20(2):197-204. PubMed ID: 23239801 [Abstract] [Full Text] [Related]
20. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Murat JB, Dard C, Fricker Hidalgo H, Dardé ML, Brenier-Pinchart MP, Pelloux H. Clin Vaccine Immunol; 2013 Aug 23; 20(8):1203-12. PubMed ID: 23740928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]